Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-015704
Filing Date
2025-02-06
Accepted
2025-02-06 20:21:04
Documents
1
Period of Report
2025-02-04

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5660
  Complete submission text file 0000950170-25-015704.txt   7222
Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Issuer) CIK: 0001819133 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address TANGO THERAPEUTICS, INC. 100 BINNEY STREET, UNIT 700 CAMBRIDGE MA 02142
Business Address
Barry Douglas (Reporting) CIK: 0001890662 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39485 | Film No.: 25598898